Plasmodium falciparum genotype diversity in artemisinin derivatives treatment failure patients along the Thai-Myanmar border
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Genetic characteristics of Plasmodium falciparum may play a role in the treatment outcome of malaria infection. We have studied the association between diversity at the merozoite surface protein-1 (msp-1), msp-2, and glutamate-rich protein (glurp) loci and the treatment outcome of uncomplicated falciparum malaria patients along the Thai-Myanmar border who were treated with artemisinin derivatives combination therapy. P. falciparum isolates were collected prior to treatment from 3 groups of patients; 50 cases of treatment failures, 50 recrudescences, and 56 successful treatments. Genotyping of the 3 polymorphic markers was analyzed by nested PCR. The distribution of msp-1 alleles was significantly different among the 3 groups of patients but not the msp-2 and glurp alleles. The allelic frequencies of K1 and MAD20 alleles of msp1 gene were higher while RO33 allele was significantly lower in the successful treatment group. Treatment failure samples had a higher median number of alleles as compared to the successful treatment group. Specific genotypes of msp-1, msp-2, and glurp were significantly associated with the treatment outcomes. Three allelic size variants were significantly higher among the isolates from the treatment failure groups, i.e., K1270-290, 3D7610-630, G650-690, while 2 variants, K1150-170, and 3D7670-690 were significantly lower. In conclusion, the present study reports the differences in multiplicity of infection and distribution of specific alleles of msp-1, msp-2, and glurp genes in P. falciparum isolates obtained from treatment failure and successful treatment patients following artemisinin derivatives combination therapy.
Abstract
Genetic characteristics of Plasmodium falciparum may play a role in the treatment outcome of malaria infection. We have studied the association between diversity at the merozoite surface protein-1 (msp-1), msp-2, and glutamate-rich protein (glurp) loci and the treatment outcome of uncomplicated falciparum malaria patients along the Thai-Myanmar border who were treated with artemisinin derivatives combination therapy. P. falciparum isolates were collected prior to treatment from 3 groups of patients; 50 cases of treatment failures, 50 recrudescences, and 56 successful treatments. Genotyping of the 3 polymorphic markers was analyzed by nested PCR. The distribution of msp-1 alleles was significantly different among the 3 groups of patients but not the msp-2 and glurp alleles. The allelic frequencies of K1 and MAD20 alleles of msp1 gene were higher while RO33 allele was significantly lower in the successful treatment group. Treatment failure samples had a higher median number of alleles as compared to the successful treatment group. Specific genotypes of msp-1, msp-2, and glurp were significantly associated with the treatment outcomes. Three allelic size variants were significantly higher among the isolates from the treatment failure groups, i.e., K1270-290, 3D7610-630, G650-690, while 2 variants, K1150-170, and 3D7670-690 were significantly lower. In conclusion, the present study reports the differences in multiplicity of infection and distribution of specific alleles of msp-1, msp-2, and glurp genes in P. falciparum isolates obtained from treatment failure and successful treatment patients following artemisinin derivatives combination therapy.
참고문헌 (20)
- Na-Bangchang K, "Current malaria status and distribution of drug resistance in East and Southeast Asia with special focus to Thailand", Tohoku J Exp Med, 211, pp.99~113 (2007)
- Na-Bangchang K, "Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border : integration of chinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity", Malar J, 12, pp.263~ (2013)
- Satimai W, "Efficacy and safety of artemether-lumefantrine(Coartem®)for the treatment of uncomplicated Plasmodium falciparum malaria in Ranong and Tak provinces", Dis Control J, 39, pp.129~138 (2013)
- Holder AA, "A malaria merozoite surface protein(MSP1)-structure, processing and function", Mem Inst Oswaldo Cruz, 87, pp.37~42 (1992)
- Prescott N, "Plasmodium falciparum genetic diversity can be characterized using the polymorphic merozoite surface antigen 2(MSA-2)gene as a single locus marker", Mol Biochem Parasitol, 63, pp.203~212 (1994)
- Snounou G, "Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand", Trans R Soc Trop Med Hyg, 93, pp.369~374 (1999)
- Takara S, "Evidence for intragenic recombination in Plasmodium falciparum : identification of a novel allele family in block 2 of merozoite surface protein-1 : Asembo Bay Area Cohort Project XIV", Mol Biochem Parasitol, 125, pp.163~171 (2002)
- Basco LK, "Molecular epidemiology of malaria in Yaounde, Cameroon. VIII. Multiple Plasmodium falciparum infections in symptomatic patients", Am J Trop Med Hyg, 65, pp.798~803 (2001)
- Kiwanuka GN, "Genetic diversity in Plasmodium falciparum merozoite surface protein-1 and 2 coding genes and its implications in malaria epidemiology: a review of published studies from 1997-2007", J Vector Borne Dis, 46, pp.1~12 (2009)
- Atroosh WM, "Genetic diversity of Plasmodium falciparum isolates from Pahang, Malaysia based on MSP-1 and MSP-2 genes", Parasit Vectors, 4, pp.233~ (2011)
- Amodu OK, "Genetic diversity of the msp-1 locus and symptomatic malaria in south-west Nigeria", Acta Trop, 95, pp.226~232 (2005)
- Färnert A, "Polyclonal Plasmodium falciparum malaria in travelers and selection of antifolate mutations after proguanil prophylaxis", Am J Trop Med Hyg, 66, pp.487~491 (2002)
- Cattamanchi A, "Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study : comparison of results based on genotyping of msp-1, msp-2, and glurp", Am J Trop Med Hyg, 68, pp.133~139 (2003)
- Mwingira F, "Plasmodium falciparum msp-1, msp-2 and glurp allele frequency and diversity in sub-Saharan Africa", Malar J, 10, pp.79~ (2011)
- "Recommended genotyping procedure (RGPs) to identify parasite populations" (2007)[URL]
- Kiwuwa MS, "Genetic diversity of Plasmodium falciparum infections in mild and severe malaria of children from Kampala, Uganda", Parasitol Res, 112, pp.1691~1700 (2013)
- Mayengue PI, "Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum isolates from Brazzaville, Republic of Congo", Malar J, 10, pp.276~ (2011)
- Ashley EA, "Spread of artemisinin resistance in Plasmodium falciparum malaria", N Engl J Med, 371, pp.411~423 (2014)
- Gosi P, "Evaluation of parasite subpopulations and genetic diversity of the msp1, msp2 and glurp genes during and following artesunate monotherapy treatment of Plasmodium falciparum malaria in western Cambodia", Malar J, 12, pp.403~ (2013)
- Robert F, "Extensive genetic diversity of Plasmodium falciparum isolates collected from patients with severe malaria in Dakar, Senegal", Trans R Soc Trop Med Hyg, 90, pp.704~711 (1996)